Breast Cancer Chemosensitivity
In Breast Cancer Chemosensitivity, a group of world leading experts review critical aspects of resistance to systemic therapy in breast cancer patients. Beginning with a clinical overview of the problem Breast Cancer Chemosensitivity moves on to focus on the latest findings of molecular mechanisms o...
Other Authors: | , |
---|---|
Format: | eBook |
Language: | English |
Published: |
New York, NY
Springer New York
2007, 2007
|
Edition: | 1st ed. 2007 |
Series: | Advances in Experimental Medicine and Biology
|
Subjects: | |
Online Access: | |
Collection: | Springer eBooks 2005- - Collection details see MPG.ReNa |
Table of Contents:
- Overview of Resistance to Systemic Therapy in Patients with Breast Cancer
- Roles of Multidrug Resistance Genes in Breast Cancer Chemoresistance
- Therapy-Induced Apoptosis in Primary Tumors
- Cell Cycle Deregulation in Breast Cancer: Insurmountable Chemoresistance or Achilles’ Heel?
- p53, BRCA1 and Breast Cancer Chemoresistance
- Integrin-Mediated Adhesion: Tipping the Balance between Chemosensitivity and Chemoresistance
- Insulin-Like Growth Factors and Breast Cancer Therapy
- EGF Receptor in Breast Cancer Chemoresistance
- Molecular Mechanisms of ErbB2-Mediated Breast Cancer Chemoresistance
- Estrogen Receptors in Resistance to Hormone Therapy
- Novel Approaches for Chemosensitization of Breast Cancer Cells: The E1A Story